Description
Liraglutide is a GLP-1 receptor agonist, originally developed for type 2 diabetes and later approved for weight management under the brand names Victoza (diabetes) and Saxenda (weight loss). What It Does:
-
Mimics GLP-1: A hormone that increases insulin secretion and reduces appetite.
-
Delays gastric emptying: Helps you feel full longer.
-
Reduces hunger: Acts on appetite centers in the brain.
“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
DISCLAIMER
For research purposes solely, we are unable to offer protocols for personal or human applications. Kindly refrain from making such requests.
Product Usage Notice: This item is exclusively meant for research and laboratory testing. It is not suitable for consumption by humans or animals. Only licensed professionals should handle it. It is neither a medication, food item, nor cosmetic, and must not be incorrectly portrayed.
Reviews
There are no reviews yet.